Understanding what drives breast cancer


 

Dr Clare Davies

“The University of Birmingham’s School of Cancer Sciences is pioneering a new approach to breast cancer research, seeking to combat the increasing resistance to treatments of the disease that claims around 11,000 lives annually. The research, funded by the Birmingham Fellowship is seeking to understand a group of enzymes, known as Protein Arginine Methyltranferases (PRMTs), which are elevated in breast cancer patients.”

Read full opinion

Have your say

Feedback